InfuSystem Holdings (INFU) Non-Current Deferred Tax Liability (2010 - 2020)
InfuSystem Holdings (INFU) posted Non-Current Deferred Tax Liability of $120000.0 for Q3 2020, up 3.45% on a QoQ basis from $116000.0 in Q2 2020, and up 57.89% year-over-year from $76000.0 in Q4 2019.
InfuSystem Holdings (INFU) Non-Current Deferred Tax Liability (2010 - 2020) Analysis & Trends
InfuSystem Holdings' Non-Current Deferred Tax Liability history runs 8 years deep, the most recent figure standing at $120000.0 for Q3 2020.
- Quarterly Non-Current Deferred Tax Liability rose 57.89% year-over-year to $120000.0 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $120000.0 (up 57.89% YoY) and the FY2019 annual result came in at $104000.0, changed N/A from the prior year.
- Non-Current Deferred Tax Liability was $120000.0 for Q3 2020 at InfuSystem Holdings, up from $116000.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $120000.0 in Q3 2020 and bottomed at $29000.0 in Q1 2019.
- A 4-year average of $82363.6 and a median of $76000.0 in 2019 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2019 — Non-Current Deferred Tax Liability slumped 66.28% — and 2020, when it soared 289.66%.
- InfuSystem Holdings' Non-Current Deferred Tax Liability stood at $62000.0 in 2017, then changed by 0.0% to $62000.0 in 2018, then surged by 67.74% to $104000.0 in 2019, then advanced by 15.38% to $120000.0 in 2020.
- Business Quant data shows INFU's Non-Current Deferred Tax Liability at $120000.0 in Q3 2020, $116000.0 in Q2 2020, and $113000.0 in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 120,000.00 |
| Sep 30, 2020 | 120,000.00 |
| Jun 30, 2020 | 116,000.00 |
| Jun 30, 2020 | 116,000.00 |
| Mar 31, 2020 | 113,000.00 |
| Mar 31, 2020 | 113,000.00 |
| Dec 31, 2019 | 104,000.00 |
| Dec 31, 2019 | 104,000.00 |
| Sep 30, 2019 | 76,000.00 |
| Sep 30, 2019 | 76,000.00 |
| Jun 30, 2019 | 76,000.00 |
| Jun 30, 2019 | 76,000.00 |
| Mar 31, 2019 | 29,000.00 |
| Mar 31, 2019 | 29,000.00 |
| Sep 30, 2018 | 62,000.00 |
| Sep 30, 2018 | 62,000.00 |
| Jun 30, 2018 | 62,000.00 |
| Jun 30, 2018 | 62,000.00 |
| Mar 31, 2018 | 86,000.00 |
| Mar 31, 2018 | 86,000.00 |